| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |